July 28, 2017 5:24 AM ET

Biotechnology

Company Overview of Sangamo Therapeutics, Inc.

Executive Profile

H. Stewart Parker MBA

AgeTotal Calculated CompensationThis person is connected to 9 Board Members in 9 different organizations across 9 different industries.

See Board Relationships
61$98,646

Background

Ms. H. Stewart Parker, MBA, is the Principal of Parker BioConsulting. Ms. Parker served as the Chief Executive Officer of Infectious Disease Research Institute (IDRI) since March 1, 2011 to 2014. She served as the President and Chief Executive Officer of AmpliPhi Biosciences Corporation from 1989 to November 6, 2008 which she founded in 1992. She has over 30 years of industry experience. She served in various capacities at Immunex Corporation from August 1981 to 1992 ...

Corporate Headquarters

501 Canal Boulevard
Richmond, California 94804

United States

Phone: 510-970-6000
Fax: 510-236-8951

Board Members Memberships

Director
Director
Director
Director
2010-Present
Independent Director
2014-Present
Chairman
2014-Present
Director
2016-Present
Chairman of the Board

Education

BA
University of Washington
MBA
University of Washington

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$63,750
Total Calculated Compensation$98,646
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Kenneth T. Mills Chief Executive Officer, President and Director
Regenxbio Inc.
$514.9K
Matthew Craig Kapusta Chief Executive Officer, Chief Financial Officer and Executive Director
uniQure N.V.
$522.3K
Katrine S. Bosley Chief Executive Officer, President and Director
Editas Medicine, Inc.
$450.0K
Steven M. Paul M.D.Chief Executive Officer, President and Director
Voyager Therapeutics, Inc.
$485.1K
Rodger Novak M.D.Co-Founder, Chief Executive Officer and Director
CRISPR Therapeutics AG
$436.9K
Compensation as of Fiscal Year 2016.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Sangamo Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.